Provided by Tiger Trade Technology Pte. Ltd.

NeuroPace Inc.

14.03
+0.01000.07%
Post-market: 14.030.00000.00%19:30 EDT
Volume:115.98K
Turnover:1.63M
Market Cap:478.34M
PE:-24.66
High:14.22
Open:14.14
Low:13.87
Close:14.02
52wk High:19.60
52wk Low:8.61
Shares:34.09M
Float Shares:23.28M
Volume Ratio:0.73
T/O Rate:0.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5690
EPS(LYR):-0.6560
ROE:-103.27%
ROA:-7.47%
PB:40.25
PE(LYR):-21.39

Loading ...

NeuroPace attends ASSFN meeting, spotlights expanding role of responsive neuromodulation in epilepsy care

Reuters
·
May 29

NeuroPace wins FDA approval for ECoG Assistant AI epilepsy feature

Reuters
·
May 29

Neuropace Announces FDA Approval of Ecog Assistant™, Advancing AI-Driven Epilepsy Care

THOMSON REUTERS
·
May 29

Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO) and NeuroPace (NPCE)

TIPRANKS
·
May 27

NeuroPace price target raised to $20 from $19 at H.C. Wainwright

TIPRANKS
·
May 16

NeuroPace Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 16

NeuroPace Earnings Call Highlights RNS Growth Momentum

TIPRANKS
·
May 14

NeuroPace (NPCE) Receives a Buy from Lake Street

TIPRANKS
·
May 13

NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers

TIPRANKS
·
May 13

Neuropace Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

NeuroPace Q1 Loss Narrows, Revenue Declines

MT Newswires Live
·
May 13

NeuroPace Q1 revenue rises 20%, beats estimates, raises 2026 outlook

Reuters
·
May 13

NeuroPace Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $22.068M Beat $21.644M Estimate

Benzinga Earnings
·
May 13

NeuroPace Q1 net loss widens to $6.7 million; revenue rises 20.1% to $22 million

Reuters
·
May 13

BRIEF-NeuroPace, Inc. Q1 EPS USD -0.2

Reuters
·
May 13

Neuropace, Inc. Q1 EPS USD -0.2

THOMSON REUTERS
·
May 13

Press Release: NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

Dow Jones
·
May 13

Neuropace Inc expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 09

Press Release: NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026

Dow Jones
·
Apr 30

NeuroPace reports 82% median seizure reduction in 3-year RNS post-approval study

Reuters
·
Apr 27